Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Psychiatry & Behavioral Health

Advertisement

Advertisement

Featured

marc agronin md
Blog
Alzheimer Disease Prevention: Part 2
07/29/2024
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated...
07/29/2024
Psych Congress Network
From Psych Congress Network
lab work
News
Dosing Starts in Pharmacokinetics Study of AD04 for Alcohol Use Disorder
07/08/2024
A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.
A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.
A pharmacokinetics study of...
07/08/2024
Psych Congress Network
From Psych Congress Network
andrew penn
Videos
Decoding the FDA Committee's Decision to Reject MDMA-Assisted Therapy: Part 2
07/01/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP,...
07/01/2024
Psych Congress Network
From Psych Congress Network
Alzheimer and cognitive decline graphic
News
Novel AD Treatment Approach Shows Promise in First Human Trial
06/25/2024
Exploratory outcomes from a phase 2a trial suggest that the first-in-class small molecule LM11A-31 slowed progression of pathophysiological features of mild to moderate Alzheimer disease (AD) over 26 weeks.
Exploratory outcomes from a phase 2a trial suggest that the first-in-class small molecule LM11A-31 slowed progression of pathophysiological features of mild to moderate Alzheimer disease (AD) over 26 weeks.
Exploratory outcomes from a...
06/25/2024
Psych Congress Network
From Psych Congress Network
andrew penn
Videos
Decoding the FDA Committee's Decision to Reject MDMA-Assisted Therapy With Andrew Penn, MS, PMHNP
06/21/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP,...
06/21/2024
Psych Congress Network
From Psych Congress Network
Dr Craig Chepke
Exclusive Interview
Dr Craig Chepke Appointed Scientific Director of Psych Congress, to Co-Chair Upcoming Elevate Meeting
05/21/2024
Meagan Thistle
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his...
05/21/2024
Psych Congress Network
From Psych Congress Network
News
One Year After ‘X Waiver’ Axing, Few New Patients Prescribed Meds for OUD
05/15/2024
Brionna Mendoza
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of...
05/15/2024
Psych Congress Network
From Psych Congress Network
ketamine brain image
News
Study Findings Support Esketamine and Psilocybin as Effective TRD Treatments
05/14/2024
Meagan Thistle
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and...
05/14/2024
Psych Congress Network
From Psych Congress Network
rx summit
News
RX Summit Presenters Embrace Harm Reduction for Recovery-Ready Communities
04/09/2024
Jolynn Tumolo
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for...
04/09/2024
Psychiatry & Behavioral Health
fda
News
FDA Approves Iloperidone for Acute Treatment of Bipolar I Disorder
04/08/2024
Meagan Thistle
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for...
04/08/2024
Psych Congress Network
From Psych Congress Network
Client at Pharmacy
News
Financial, Insurance Barriers May Interfere with Buprenorphine Dispensing at Pharmacy
04/02/2024
Jolynn Tumolo
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance...
04/02/2024
Psychiatry & Behavioral Health

Advertisement

Advertisement

Advertisement

https://www.hmpgloballearningnetwork.com/site/pcnpi

Advertisement

Advertisement

Multimedia

andrew penn
Videos
Decoding the FDA Committee's Decision to Reject MDMA-Assisted Therapy: Part 2
07/01/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP,...
07/01/2024
Psych Congress Network
andrew penn
Videos
Decoding the FDA Committee's Decision to Reject MDMA-Assisted Therapy With Andrew Penn, MS, PMHNP
06/21/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP,...
06/21/2024
Psych Congress Network
Dr Craig Chepke
Exclusive Interview
Dr Craig Chepke Appointed Scientific Director of Psych Congress, to Co-Chair Upcoming Elevate Meeting
05/21/2024
Meagan Thistle
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his...
05/21/2024
Psych Congress Network
Amber Hoberg, MSN, APRN, PMHNP-BC
Videos
Clinical Pearls to Enhance Tardive Dyskinesia Treatment
01/10/2024

Featuring Amber Hoberg, MSN, APRN, PMHNP-BC

Featuring Amber Hoberg, MSN, APRN, PM...
n this video, Tardive Dyskinesia Section Editor Amber Hoberg, MSN, APRN, PMHNP-BC, of Med Management Associates, offers clinical pearls that clinicians can implement to optimize their tardive dyskinesia care.
n this video, Tardive Dyskinesia Section Editor Amber Hoberg, MSN, APRN, PMHNP-BC, of Med Management Associates, offers clinical pearls that clinicians can implement to optimize their tardive dyskinesia care.
n this video, Tardive Dyskinesia...
01/10/2024
Psych Congress Network
Dr Greg Mattingly
Videos
Day 2: Late-Breaking Updates From the National Academy of Sciences Conference on Adult ADHD
12/14/2023

Featuring Greg Mattingly, MD

Featuring Greg Mattingly, MD
Greg Mattingly, MD, gives exclusive updates from day 2 of the National Academy of Sciences Adult Attention-Deficit/Hyperactivity Disorder: Diagnosis, Treatment, and Implications for Drug Development Workshop.
Greg Mattingly, MD, gives exclusive updates from day 2 of the National Academy of Sciences Adult Attention-Deficit/Hyperactivity Disorder: Diagnosis, Treatment, and Implications for Drug Development Workshop.
Greg Mattingly, MD, gives...
12/14/2023
Psych Congress Network
Dr Maletic
Videos
Emerging Research and Technology: Beyond One-Size-Fits-All Medicine
12/04/2023

With Vladimir Maletic, MD

With Vladimir Maletic, MD
Dr Maletic discusses how new research shows promise for advancing our comprehension of brain networks, circuits, and neurotransmitters to benefit those with neurological and psychiatric disorders
Dr Maletic discusses how new research shows promise for advancing our comprehension of brain networks, circuits, and neurotransmitters to benefit those with neurological and psychiatric disorders
Dr Maletic discusses how new...
12/04/2023
Psychiatry & Behavioral Health
Understanding the ‘Neurochemical Alphabet’ to Inform Treatment
Videos
Understanding the ‘Neurochemical Alphabet’ to Inform Treatment
11/28/2023
In his recent NEI Congress session, Vladimir Maletic, MD, MS, University of South Carolina, Greenville, examined the neurobiologic underpinning of major psychiatric conditions such as major depressive disorder, bipolar disorder, and anxiety....
In his recent NEI Congress session, Vladimir Maletic, MD, MS, University of South Carolina, Greenville, examined the neurobiologic underpinning of major psychiatric conditions such as major depressive disorder, bipolar disorder, and anxiety....
In his recent NEI Congress...
11/28/2023
Psychiatry & Behavioral Health
Dr Vlad Maletic
Videos
Beyond Neurotransmitters: Unraveling the Brain Circuitry of Mental Health
11/27/2023

Featuring Vladimir Maletic, MD.

Featuring Vladimir Maletic, MD. ...
Vladimir Maletic, MD, explores the complexities of brain circuitry and the neurobiological basis of major psychiatric conditions.
Vladimir Maletic, MD, explores the complexities of brain circuitry and the neurobiological basis of major psychiatric conditions.
Vladimir Maletic, MD, explores...
11/27/2023
Psychiatry & Behavioral Health
Dr Ramawamy Viswanathan
Videos
Unlocking the Unique Aspects of Seasonal Affective Disorder for Better Patient Support This Winter
11/21/2023
President-Elect of the APA, Ramaswamy Viswanathan, MD, DrMedSc shares what clinicians need to know about Seasonal Affective Disorder (SAD), and how to better support patients experiencing symptoms.
President-Elect of the APA, Ramaswamy Viswanathan, MD, DrMedSc shares what clinicians need to know about Seasonal Affective Disorder (SAD), and how to better support patients experiencing symptoms.
President-Elect of the APA,...
11/21/2023
Psych Congress Network
Using Pharmacokinetics and Pharmacodynamics to Prescribe Antipsychotics
Videos
Using Pharmacokinetics and Pharmacodynamics to Prescribe Antipsychotics
11/13/2023

With Jonathan Meyer, MD

With Jonathan Meyer, MD
Dr Jonathan Meyer discusses his NEI 2023 session "Level Up: Using Plasma Levels, Pharmacokinetics and Pharmacodynamics to Guide Antipsychotic Prescribing," the importance of understanding the kinetics of long-acting injectables, and more.
Dr Jonathan Meyer discusses his NEI 2023 session "Level Up: Using Plasma Levels, Pharmacokinetics and Pharmacodynamics to Guide Antipsychotic Prescribing," the importance of understanding the kinetics of long-acting injectables, and more.
Dr Jonathan Meyer discusses his...
11/13/2023
Psychiatry & Behavioral Health

Advertisement

Advertisement

Advertisement

From the Newsrooms

Nishi Bhopal, MD
Q&As
Dispelling Common Misconceptions About Sleep Medicine
08/08/2024
Nishi Bhopal, MD, clarifies 5 common misconceptions about sleep medicine for mental health care practice.
Nishi Bhopal, MD, clarifies 5 common misconceptions about sleep medicine for mental health care practice.
Nishi Bhopal, MD, clarifies 5...
08/08/2024
Psych Congress Network
Nishi Bhopal, MD
Q&As
The Importance of Sleep Education for Mental Health Clinicians
07/16/2024
Nishi Bhopal, MD, discusses how mental health clinicians can more closely incorporate sleep disorder screening, diagnosis, and treatment into their practices.
Nishi Bhopal, MD, discusses how mental health clinicians can more closely incorporate sleep disorder screening, diagnosis, and treatment into their practices.
Nishi Bhopal, MD, discusses how...
07/16/2024
Psych Congress Network
Nishi Bhopal, MD
Q&As
Social Media Etiquette for Mental Health Clinicians
07/01/2024
Nishi Bhopal, MD, explains how to maintain professionalism while using social media to promote one'e telehealth practice.
Nishi Bhopal, MD, explains how to maintain professionalism while using social media to promote one'e telehealth practice.
Nishi Bhopal, MD, explains how...
07/01/2024
Psych Congress Network
Nishi Bhopal, MD
Q&As
Leveraging Social Media to Support Your Practice
06/20/2024
Nishi Bhopal, MD, telehealth practitioner, providers insight into how mental health clinicians can utilize social media to improve patient outcomes and combat misinformation.
Nishi Bhopal, MD, telehealth practitioner, providers insight into how mental health clinicians can utilize social media to improve patient outcomes and combat misinformation.
Nishi Bhopal, MD, telehealth...
06/20/2024
Psych Congress Network
Nurse Kempf
Videos
Optimizing Nursing Home and Geriatric Patient Mental Health Care With Brooke Kempf, PMHNP-BC
06/03/2024

With Brooke Kempf, PMHNP-BC

With Brooke Kempf, PMHNP-BC
Join Nurse Kempf for this essential discussion on geriatric mental health care, and learn practical tips and strategies for providing compassionate and effective treatment to this vulnerable population.
Join Nurse Kempf for this essential discussion on geriatric mental health care, and learn practical tips and strategies for providing compassionate and effective treatment to this vulnerable population.
Join Nurse Kempf for this...
06/03/2024
Psych Congress Network
Sandhya Prashad, MD
Q&As
Unlocking the Power of Ketamine With Sandhya Prashad, MD
05/30/2024

Featuring Sandhya Prashad, MD

Featuring Sandhya Prashad, MD
Sandhya Prashad, MD, discusses ketamine applications for treatment-resistant depression.
Sandhya Prashad, MD, discusses ketamine applications for treatment-resistant depression.
Sandhya Prashad, MD, discusses...
05/30/2024
Psych Congress Network
Patients With Anhedonia More Severely Affected Than Other Patients With MDD
News
Patients With Anhedonia More Severely Affected Than Other Patients With MDD
05/30/2024
Evi Arthur
Patients with major depressive disorder and anhedonia may have more severe depressive symptoms than patients with MDD and no/low anhedonia (other-MDD), according to results presented via poster at Psych Congress Elevate. 
Patients with major depressive disorder and anhedonia may have more severe depressive symptoms than patients with MDD and no/low anhedonia (other-MDD), according to results presented via poster at Psych Congress Elevate. 
Patients with major depressive...
05/30/2024
Psych Congress Network
Dr Craig Chepke
Exclusive Interview
Dr Craig Chepke Appointed Scientific Director of Psych Congress, to Co-Chair Upcoming Elevate Meeting
05/21/2024
Meagan Thistle
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his...
05/21/2024
Psych Congress Network
rx summit
News
RX Summit Presenters Embrace Harm Reduction for Recovery-Ready Communities
04/09/2024
Jolynn Tumolo
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for...
04/09/2024
Psychiatry & Behavioral Health
Client at Pharmacy
News
Financial, Insurance Barriers May Interfere with Buprenorphine Dispensing at Pharmacy
04/02/2024
Jolynn Tumolo
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance...
04/02/2024
Psychiatry & Behavioral Health

Advertisement

Blogs

marc agronin md
Blog
Alzheimer Disease Prevention: Part 2
07/29/2024
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated...
07/29/2024
Psych Congress Network
Chan_Khan_Digital Mental Health
Blog
Who will use it? How to Get Digital Mental Health Apps Into the Hands of Patients
04/27/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan...
04/27/2022
Psychiatry & Behavioral Health
Chan_Khan_Digital Mental Health
Blog
How to Navigate Quality Issues With Mental Health Apps
04/21/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan...
04/21/2022
Psychiatry & Behavioral Health
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Blog
How New NPs Can Find Mentors
03/04/2022
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains...
03/04/2022
Psych Congress Network
wellbeing_anxiety_depression
Blog
A Woman's Guide to Overcoming Daily Stress and Improving Overall Well-Being
12/16/2021
This guide provides actionable tips you can implement in everyday life for improved well-being.
This guide provides actionable tips you can implement in everyday life for improved well-being.
This guide provides actionable...
12/16/2021
Psych Congress Network
Julie Carbray
Blog
Julie Carbray Welcomes You to Psych Congress
10/25/2021
A welcome message from Co-chair, Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, for the 2021 Psych Congress annual meeting in San Antonio, TX.
A welcome message from Co-chair, Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, for the 2021 Psych Congress annual meeting in San Antonio, TX.
A welcome message from Co-chair,...
10/25/2021
Psych Congress Network
Athena Robinson
Blog
Using AI to Build a Bridge Between Men and Mental Health Care
10/15/2021
Athena Robinson, PhD, discusses how artificial intelligence can help men overcome the stigma of seeking treatment for mental health disorders.
Athena Robinson, PhD, discusses how artificial intelligence can help men overcome the stigma of seeking treatment for mental health disorders.
Athena Robinson, PhD, discusses...
10/15/2021
Psych Congress Network
Struggling mom
Blog
New Models of Care Are Needed for Pregnant and Parenting Women With OUD to Reduce Avoidable Pregnancy-Associated Deaths
07/20/2021
Lydia Tschoe, MHA, and Karen Scott, MD, address the concern that pregnancy-associated deaths involving opioids have more than doubled between 2007 and 2016.
Lydia Tschoe, MHA, and Karen Scott, MD, address the concern that pregnancy-associated deaths involving opioids have more than doubled between 2007 and 2016.
Lydia Tschoe, MHA, and Karen...
07/20/2021
Psych Congress Network
Blog
Opportunity, Not Obstacles: Pandemic Innovations in Psychiatry Are Here to Stay
05/28/2021
Craig Chepke, M.D., FAPA: From telepsychiatry to drive-up injection sites, new, inventive strategies for patient-centered care spurred by COVID-19 pandemic could drive lasting change.
Craig Chepke, M.D., FAPA: From telepsychiatry to drive-up injection sites, new, inventive strategies for patient-centered care spurred by COVID-19 pandemic could drive lasting change.
Craig Chepke, M.D., FAPA: From...
05/28/2021
Psych Congress Network
Blog
Waiting to Emerge From the Pandemic: What Awaits Us?
04/19/2021
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: How much energy will it take to overcome the inertia that has befallen our daily lives? Will we reenact a simulacrum of how things were before, or will we find, deep within ourselves, the capacity for reimagination of what could be?
BLOG: How much energy will it take to overcome the inertia that has befallen our daily lives? Will we reenact a simulacrum of how things were before, or will we find, deep within ourselves, the capacity for reimagination of what could be?
BLOG: How much energy will it...
04/19/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Popular Now

Short-Term and Potential Long-Term Impacts on Patients with TD
Videos
Short-Term and Potential Long-Term Impacts on Patients with TD
08/06/2020
08/06/2020
Psychiatry & Behavioral Health
News
Hazelden Betty Ford: Virtual IOP Outcomes Match In-Person Offerings
10/14/2020
Early data published by Hazelden Betty Ford Foundation’s Butler Center for Research suggests that virtual intensive outpatient services have been as effective as on-site IOP treatment, a promising development as providers have moved many...
Early data published by Hazelden Betty Ford Foundation’s Butler Center for Research suggests that virtual intensive outpatient services have been as effective as on-site IOP treatment, a promising development as providers have moved many...
Early data published by Hazelden...
10/14/2020
Addiction Professional
Blog
Will new organizational structures, leadership competencies be de rigueur in the future?
02/04/2011
At almost any point during the history of community mental health, “change and challenge” would aptly describe the times. From the initial infrastructure building, to the evolution of the care continuum, to the near escapes from public policy...
At almost any point during the history of community mental health, “change and challenge” would aptly describe the times. From the initial infrastructure building, to the evolution of the care continuum, to the near escapes from public policy...
At almost any point during the...
02/04/2011
Behavioral Healthcare Executive
image
APNA ISS: Achieving and Maintaining Improved Quality of Life in Patients with Tardive Dyskinesia
06/14/2021
06/14/2021
Psychiatry & Behavioral Health
Tips to Conducting the AIMS
06/24/2021
06/24/2021
Psychiatry & Behavioral Health

Advertisement

Advertisement

Advertisement

Sign Up

Psychiatry & Behavioral Health Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement